Issue Price
₹139
Per Share
GMP
+₹2
+1.44% Grey Market
Est. Listing
₹141
Expected Price
Min. Application
₹278,000
2 lots × 1000 shares
Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms.der injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare.Product portfolio:Liquid Injectables: 58 products are offered under this categoryDry powder injectables: 15 products under this categoryIt offers comprehensive range of products, including generic drugs, branded pharmaceuticals, over the counter (OTC) products, and other medications.The company operates on a B2B model, focusing exclusively on contract manufacturing. It develop formulations for various companies in accordance with their specific requirements and product specifications. It is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificate issued by the Food & Drugs Administration, Madhya Pradesh.It has two manufacturing facilities in Indore, Madhya Pradesh.Competitive StrengthsMulti-product capability and diversified product portfolioExperienced promoters, management and employees.Quality assuranceEstablished client relationship
Bio Medica Laboratories Ltd proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| QIB (Ex Anchor) | 36,000 | — | ₹0.50 Cr | 15.94x |
| NII / HNI | 1,755,000 | — | ₹24.39 Cr | 0.28x |
| Retail (RII) | 1,792,000 | — | ₹24.91 Cr | 1.42x |
| Market Maker | 189,000 | — | ₹2.63 Cr | — |
| TOTAL | 3,583,000 | 100.00% | ₹49.80 Cr | 1.01x |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹139,000 |
| Retail (Max) | 13 | 13,000 | ₹1,807,000 |
| sNII (Min) | 14 | 14,000 | ₹1,946,000 |
| bNII (Min) | 68 | 68,000 | ₹9,452,000 |
| Particulars | 30 Nov 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue from Operations | 28.63 | 38.33 | 15.34 |
| EBITDA | 13.45 | 15.21 | 5.63 |
| Profit After Tax (PAT) | 8.66 | 9.79 | 2.50 |
| Net Worth | 17.12 | 14.73 | 4.94 |
| Total Assets | 65.17 | 39.12 | 19.53 |
| Reserves & Surplus | 7.94 | 5.55 | 4.84 |
| Total Borrowings | 38.17 | 15.01 | 10.49 |